Eric Crombez
Chief Medical Officer and Executive Vice President
Other
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Medical Officer and Executive Vice President | $630,231 | $4,002,173 |
| 2024 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Medical Officer and Executive Vice President | $591,846 | $4,298,223 |
Executive changes
Earnings-call appearances
-
Ultragenyx Pharmaceutical Inc. Q1 FY2026 Earnings Call2026-05-05
Ultragenyx Pharmaceutical Inc. (RARE)
-
Barclays 28th Annual Global Healthcare Conference2026-03-10
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q4 FY2025 Earnings Call2026-02-12
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q3 FY2025 Earnings Call2025-11-04
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q2 FY2025 Earnings Call2025-08-05
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q4 FY2024 Earnings Call2025-02-13
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q3 FY2024 Earnings Call2024-11-05
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q2 FY2024 Earnings Call2024-08-01
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q1 FY2024 Earnings Call2024-05-02
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q4 FY2023 Earnings Call2024-01-08
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q3 FY2023 Earnings Call2023-10-16
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q2 FY2023 Earnings Call2023-08-03
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q1 FY2023 Earnings Call2023-05-04
Ultragenyx Pharmaceutical Inc. (RARE)